248 related articles for article (PubMed ID: 32237007)
1. Prognostic impact of hyponatraemia and hypernatraemia at admission and discharge in heart failure patients with preserved, mid-range and reduced ejection fraction.
Vicent L; Alvarez-Garcia J; Gonzalez-Juanatey JR; Rivera M; Segovia J; Worner F; Bover R; Pascual-Figal D; Vázquez R; Cinca J; Fernandez-Aviles F; Martinez-Sellés M
Intern Med J; 2021 Jun; 51(6):930-938. PubMed ID: 32237007
[TBL] [Abstract][Full Text] [Related]
2. Short and long-term prognostic value of hyponatremia in heart failure with preserved ejection fraction versus reduced ejection fraction: An analysis of the Korean Acute Heart Failure registry.
Park JJ; Cho YJ; Oh IY; Park HA; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
Int J Cardiol; 2017 Dec; 248():239-245. PubMed ID: 28821416
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan.
Shiga T; Suzuki A; Haruta S; Mori F; Ota Y; Yagi M; Oka T; Tanaka H; Murasaki S; Yamauchi T; Katoh J; Hattori H; Kikuchi N; Watanabe E; Yamada Y; Haruki S; Kogure T; Suzuki T; Uetsuka Y; Hagiwara N;
ESC Heart Fail; 2019 Jun; 6(3):475-486. PubMed ID: 30829002
[TBL] [Abstract][Full Text] [Related]
4. Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction.
Vicent L; Cinca J; Vazquez-García R; Gonzalez-Juanatey JR; Rivera M; Segovia J; Pascual-Figal D; Bover R; Worner F; Delgado-Jiménez J; Fernández-Avilés F; Martínez-Sellés M
Intern Med J; 2019 Dec; 49(12):1505-1513. PubMed ID: 30887642
[TBL] [Abstract][Full Text] [Related]
5. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
Sartipy U; Dahlström U; Fu M; Lund LH
JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
[TBL] [Abstract][Full Text] [Related]
6. Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
Son MK; Park JJ; Lim NK; Kim WH; Choi DJ
Heart; 2020 Aug; 106(15):1160-1168. PubMed ID: 32341140
[TBL] [Abstract][Full Text] [Related]
7. Impact of diabetes on mortality and rehospitalization in acute heart failure patients stratified by ejection fraction.
Al-Jarallah M; Rajan R; Al-Zakwani I; Dashti R; Bulbanat B; Ridha M; Sulaiman K; Alsheikh-Ali AA; Panduranga P; AlHabib KF; Al Suwaidi J; Al-Mahmeed W; AlFaleh H; Elasfar A; Al-Motarreb A; Bazargani N; Asaad N; Amin H
ESC Heart Fail; 2020 Feb; 7(1):297-305. PubMed ID: 31825180
[TBL] [Abstract][Full Text] [Related]
8. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.
Farmakis D; Simitsis P; Bistola V; Triposkiadis F; Ikonomidis I; Katsanos S; Bakosis G; Hatziagelaki E; Lekakis J; Mebazaa A; Parissis J
Clin Res Cardiol; 2017 May; 106(5):359-368. PubMed ID: 27999929
[TBL] [Abstract][Full Text] [Related]
9. Age-dependent differences in clinical phenotype and prognosis in heart failure with mid-range ejection compared with heart failure with reduced or preserved ejection fraction.
Chen X; Savarese G; Dahlström U; Lund LH; Fu M
Clin Res Cardiol; 2019 Dec; 108(12):1394-1405. PubMed ID: 30980205
[TBL] [Abstract][Full Text] [Related]
10. The epidemiology of intensive care unit-acquired hyponatraemia and hypernatraemia in medical-surgical intensive care units.
Stelfox HT; Ahmed SB; Khandwala F; Zygun D; Shahpori R; Laupland K
Crit Care; 2008; 12(6):R162. PubMed ID: 19094227
[TBL] [Abstract][Full Text] [Related]
11. Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction.
Abdul-Rahim AH; Shen L; Rush CJ; Jhund PS; Lees KR; McMurray JJV;
Eur J Heart Fail; 2018 Jul; 20(7):1139-1145. PubMed ID: 29493058
[TBL] [Abstract][Full Text] [Related]
12. Dysnatraemia in heart failure.
Deubner N; Berliner D; Frey A; Güder G; Brenner S; Fenske W; Allolio B; Ertl G; Angermann CE; Störk S
Eur J Heart Fail; 2012 Oct; 14(10):1147-54. PubMed ID: 22820314
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Prognostic Significance of Plasma B-Type Natriuretic Peptide Level in Patients With Acute Heart Failure With Reduced, Mid-Range, and Preserved Ejection Fractions.
Hamatani Y; Nagai T; Shiraishi Y; Kohsaka S; Nakai M; Nishimura K; Kohno T; Nagatomo Y; Asaumi Y; Goda A; Mizuno A; Yasuda S; Ogawa H; Yoshikawa T; Anzai T;
Am J Cardiol; 2018 Mar; 121(6):731-738. PubMed ID: 29394996
[TBL] [Abstract][Full Text] [Related]
14. Relationship of serum sodium concentration to mortality in a wide spectrum of heart failure patients with preserved and with reduced ejection fraction: an individual patient data meta-analysis(†): Meta-Analysis Global Group in Chronic heart failure (MAGGIC).
Rusinaru D; Tribouilloy C; Berry C; Richards AM; Whalley GA; Earle N; Poppe KK; Guazzi M; Macin SM; Komajda M; Doughty RN;
Eur J Heart Fail; 2012 Oct; 14(10):1139-46. PubMed ID: 22782968
[TBL] [Abstract][Full Text] [Related]
15. Current conditions and significance of outpatient cardiac rehabilitation and home nursing-care services in heart failure patients with mid-range or preserved ejection fraction: post-hoc analysis of the REAL-HF registry.
Kitagawa T; Hidaka T; Watanabe N; Naka M; Yamaguchi M; Kanai K; Isobe M; Kihara Y; Nakano Y;
Heart Vessels; 2022 May; 37(5):745-754. PubMed ID: 34731295
[TBL] [Abstract][Full Text] [Related]
16. Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction.
Rovai S; Corrà U; Piepoli M; Vignati C; Salvioni E; Bonomi A; Mattavelli I; Arcari L; Scardovi AB; Perrone Filardi P; Lagioia R; Paolillo S; Magrì D; Limongelli G; Metra M; Senni M; Scrutinio D; Raimondo R; Emdin M; Lombardi C; Cattadori G; Parati G; Re F; Cicoira M; Villani GQ; Minà C; Correale M; Frigerio M; Perna E; Mapelli M; Magini A; Clemenza F; Bussotti M; Battaia E; Guazzi M; Bandera F; Badagliacca R; Di Lenarda A; Pacileo G; Maggioni A; Passino C; Sciomer S; Sinagra G; Agostoni P;
Eur J Heart Fail; 2019 Dec; 21(12):1586-1595. PubMed ID: 31782225
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure.
Savarese G; Vedin O; D'Amario D; Uijl A; Dahlström U; Rosano G; Lam CSP; Lund LH
JACC Heart Fail; 2019 Apr; 7(4):306-317. PubMed ID: 30852236
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of cardiac I-123-metaiodobenzylguanidine imaging in patients with reduced, mid-range, and preserved left ventricular ejection fraction admitted for acute decompensated heart failure: a prospective study in Osaka Prefectural Acute Heart Failure Registry (OPAR).
Seo M; Yamada T; Tamaki S; Watanabe T; Morita T; Furukawa Y; Kawasaki M; Kikuchi A; Kawai T; Abe M; Nakamura J; Yamamoto K; Kayama K; Kawahira M; Tanabe K; Kimura T; Ueda K; Sakamoto D; Sakata Y; Fukunami M
Eur Heart J Cardiovasc Imaging; 2021 Jan; 22(1):58-66. PubMed ID: 32091079
[TBL] [Abstract][Full Text] [Related]
19. Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction.
Löfman I; Szummer K; Dahlström U; Jernberg T; Lund LH
Eur J Heart Fail; 2017 Dec; 19(12):1606-1614. PubMed ID: 28371075
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry.
Chioncel O; Lainscak M; Seferovic PM; Anker SD; Crespo-Leiro MG; Harjola VP; Parissis J; Laroche C; Piepoli MF; Fonseca C; Mebazaa A; Lund L; Ambrosio GA; Coats AJ; Ferrari R; Ruschitzka F; Maggioni AP; Filippatos G
Eur J Heart Fail; 2017 Dec; 19(12):1574-1585. PubMed ID: 28386917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
